Release date: 2006-12-13
New measures to prevent cardiovascular disease in Europe can reduce the risk of death from coronary heart disease. If you are a man with high blood pressure, accompanied by dyslipidemia, diabetes, smoking and are over 55 years old, myocardial infarction or cause may occur. Coronary heart disease kills. However, the prevention and treatment program launched by the largest hypertension study in Europe announced today can reduce your fears: the use of calcium antagonists and statins can reduce the risk of fatal coronary heart disease and non-fatal myocardial infarction by 5%. thirteen.
Professor Hu Dayi of Peking University People's Hospital, at the press conference of the “Synchronous Interpretation of the Latest Results of the Largest Hypertension Study in Europe†held by the Cardiovascular Physician Branch of the Chinese Medical Doctor Association, said that this data from the Anglo-Scandinavian cardiac end point study The combination of calcium antagonists and statins is a new approach to the treatment and prevention of cardiovascular events in hypertensive patients.
Professor Hu explained that the study, which lasted for more than five years, is currently the largest clinical study of hypertension in Europe sponsored by Pfizer, with 19,257 hypertensive patients participating. Because most patients with hypertension have other cardiovascular risk factors besides elevated blood pressure, lowering blood pressure can significantly reduce the risk of stroke. The results showed that cholesterol was closely related to coronary heart disease and myocardial infarction; the statin Lipitor was sufficient to reduce cholesterol, myocardial infarction and coronary heart disease death.
In addition, the study also conducted a randomized and placebo treatment of 10,000 patients with normal to mildly elevated cholesterol. The results showed that combined with long-acting calcium antagonists and statins lower cholesterol can make patients Significantly reduce myocardial infarction and coronary heart disease death.
The study began in 1998 in the UK, Ireland, Sweden, Norway, Denmark, Finland and Iceland. The research report was published in the European Journal of Cardiology published yesterday. Professor Hu Dayi is the Chinese editorial board member of the publication. (China News Network)
Enhanced Freeze-free Disposable Starch Noodle Machine
Noodle Making Machine,Enhanced Noodle Machine,Noodle Machine,Automatic Noodle Making Machine
Shuangfeng County Dingyuan Machinery Manufacturing Co. Ltd.. , https://www.starchseparator.com